0FT3 Stock Overview
Provides molecular beam epitaxy (MBE) products and services for the semiconductor industry.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Riber S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.51 |
| 52 Week High | €2.85 |
| 52 Week Low | €1.46 |
| Beta | 0.97 |
| 11 Month Change | -3.83% |
| 3 Month Change | 1.21% |
| 1 Year Change | 37.91% |
| 33 Year Change | 74.31% |
| 5 Year Change | n/a |
| Change since IPO | 151.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0FT3 | GB Semiconductor | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -0.7% |
| 1Y | 37.9% | -6.5% | 6.7% |
Return vs Industry: 0FT3 exceeded the UK Semiconductor industry which returned -6.5% over the past year.
Return vs Market: 0FT3 exceeded the UK Market which returned 6.7% over the past year.
Price Volatility
| 0FT3 volatility | |
|---|---|
| 0FT3 Average Weekly Movement | n/a |
| Semiconductor Industry Average Movement | 5.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 9.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0FT3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0FT3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 119 | Annie Geoffroy | www.riber.com |
Riber S.A. provides molecular beam epitaxy (MBE) products and services for the semiconductor industry. It offers MBE systems comprising of research and pilot production system, and solutions for compound semiconductor passivation. In addition, the company provides MBE sources consisting of effusion cells, gas sources, resistive cell, and valved cracker sources, as well as MBE heaters and manipulators.
Riber S.A. Fundamentals Summary
| 0FT3 fundamental statistics | |
|---|---|
| Market cap | €53.17m |
| Earnings (TTM) | €3.40m |
| Revenue (TTM) | €39.26m |
15.7x
P/E Ratio1.4x
P/S RatioIs 0FT3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0FT3 income statement (TTM) | |
|---|---|
| Revenue | €39.26m |
| Cost of Revenue | €26.01m |
| Gross Profit | €13.25m |
| Other Expenses | €9.85m |
| Earnings | €3.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 25, 2024
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 33.74% |
| Net Profit Margin | 8.65% |
| Debt/Equity Ratio | 25.2% |
How did 0FT3 perform over the long term?
See historical performance and comparison